Next Article in Journal
When Combined with Colistin, an Otherwise Ineffective Rifampicin–Linezolid Combination Becomes Active in Escherichia coli, Pseudomonas aeruginosa, and Acinetobacter baumannii
Next Article in Special Issue
In Vitro Zika Virus Infection of Human Neural Progenitor Cells: Meta-Analysis of RNA-Seq Assays
Previous Article in Journal
Inoculation with Rhizophagus irregularis Does Not Alter Arbuscular Mycorrhizal Fungal Community Structure within the Roots of Corn, Wheat, and Soybean Crops
Previous Article in Special Issue
HHV-6A Infection and Systemic Sclerosis: Clues of a Possible Association
Review

The Use of Antimalarial Drugs against Viral Infection

1
Department of Biomedical, Surgical and Dental Sciences, University of Milano, 20133 Milan, Italy
2
Department of Pharmacological and Biomolecular Sciences, University of Milano, 20133 Milan, Italy
3
Département des Sciences de la Vie, University of Fada N’Gourma (UFDG), Fada N’Gourma BP 54, Burkina Faso
*
Author to whom correspondence should be addressed.
Microorganisms 2020, 8(1), 85; https://doi.org/10.3390/microorganisms8010085
Received: 11 December 2019 / Revised: 31 December 2019 / Accepted: 3 January 2020 / Published: 8 January 2020
(This article belongs to the Special Issue Virus-Host Interaction: From Physiology to Pathology)
In recent decades, drugs used to treat malaria infection have been shown to be beneficial for many other diseases, including viral infections. In particular, they have received special attention due to the lack of effective antiviral drugs against new emerging viruses (i.e., HIV, dengue virus, chikungunya virus, Ebola virus, etc.) or against classic infections due to drug-resistant viral strains (i.e., human cytomegalovirus). Here, we reviewed the in vitro/in vivo and clinical studies conducted to evaluate the antiviral activities of four classes of antimalarial drugs: Artemisinin derivatives, aryl-aminoalcohols, aminoquinolines, and antimicrobial drugs. View Full-Text
Keywords: antimalarial drugs; viruses; emerging infections antimalarial drugs; viruses; emerging infections
Show Figures

Figure 1

MDPI and ACS Style

D’Alessandro, S.; Scaccabarozzi, D.; Signorini, L.; Perego, F.; Ilboudo, D.P.; Ferrante, P.; Delbue, S. The Use of Antimalarial Drugs against Viral Infection. Microorganisms 2020, 8, 85. https://doi.org/10.3390/microorganisms8010085

AMA Style

D’Alessandro S, Scaccabarozzi D, Signorini L, Perego F, Ilboudo DP, Ferrante P, Delbue S. The Use of Antimalarial Drugs against Viral Infection. Microorganisms. 2020; 8(1):85. https://doi.org/10.3390/microorganisms8010085

Chicago/Turabian Style

D’Alessandro, Sarah, Diletta Scaccabarozzi, Lucia Signorini, Federica Perego, Denise P. Ilboudo, Pasquale Ferrante, and Serena Delbue. 2020. "The Use of Antimalarial Drugs against Viral Infection" Microorganisms 8, no. 1: 85. https://doi.org/10.3390/microorganisms8010085

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop